Form D/A — Kaida BioPharma Inc.
0001493152-26-040893 · filed Sep 1, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $4,100,507
- Reported amount sold
- $1,600,507
- Minimum investment
- $0
- Investors
- 44
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Kaida BioPharma Inc.
- CIK
- 1973954
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 416 SW 1ST AVENUE
FORT LAUDERDALE, FL 33301 - Phone
- (917) 683-3092
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Craig Pierson · Executive OfficerFort Lauderdale, FL Find on LinkedIn ↗
-
Stella Vnook · DirectorFort Lauderdale, FL Find on LinkedIn ↗
-
Richard Warburg · DirectorFort Lauderdale, FL Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗